ZOM

0.66% -0.0008

アフターアワーズ： .12 0.0002 +0.17%

Zomedica Corp (ZOM)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Zomedica Corp Stock (ZOM) Company Profile

Zomedica Corp

Healthcare (1169)

734-369-2555

100 Phoenix Drive, Suite 190, Ann Arbor, MI

ZOM's Discussions on Twitter

ZOM を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
ZOM Zomedica Corp	0.1198	117.40M	25.19M	-34.53M	-20.62M	-0.036
ZTS Zoetis Inc	160.46	71.85B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.08	45.58B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	14.06	44.58B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.74	19.18B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.60	13.67B	612.78M	-86.37M	-62.91M	-0.87

Zomedica Corp Stock (ZOM) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2023-01-06	開始されました	Dawson James	Buy

Zomedica Corp (ZOM) 最新ニュース

Zomedica Corp (ZOM) 財務データ

Zomedica Corp (ZOM)

Zomedica Corp Stock (ZOM) Company Profile

ZOM を他の銘柄と比較する

Zomedica Corp Stock (ZOM) Upgrades & Downgrades

Zomedica Corp (ZOM) 最新ニュース

Observations on the Zomedica Corp (AMEX:ZOM) Growth Curve - US Post News

Zomedica Corp [ZOM] stock for 18,450 USD was acquired by Blair Anthony K - Knox Daily

ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan

Zomedica Relocates Headquarters, Cuts Costs by $200,000 Annually -February 12, 2025 at 09:15 am EST - Marketscreener.com

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - ACCESS Newswire

Smart Money Move: Zomedica's New HQ Cuts Expenses in Half, Accelerates Path to Profits - StockTitan

Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners - ACCESS Newswire

Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference - ACCESS Newswire

Zomedica Corp [ZOM] Records 200-Day SMA of $0.1375 - Knox Daily

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - ACCESS Newswire

Experts predict Zomedica Corp’s (ZOM) current quarter earnings growth rate - US Post News

Zomedica Corp (ZOM) rating initates by Dawson James - Knox Daily

Zomedica (NYSEAMERICAN:ZOM) Shares Up 1.6%Here's Why - MarketBeat

Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared - ACCESS Newswire

US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians - ACCESS Newswire

Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line - ACCESS Newswire

Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs - ACCESS Newswire

Zomedica Expands International Reach with CE Certification for VetGuardian(R) System - ACCESS Newswire

Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels - ACCESS Newswire

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - ACCESS Newswire

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - ACCESS Newswire

Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America - ACCESS Newswire

Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota - ACCESS Newswire

Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product - ACCESS Newswire

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - ACCESS Newswire

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - ACCESS Newswire

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - ACCESS Newswire

Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference - ACCESS Newswire

Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - ACCESS Newswire

Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe - ACCESS Newswire

A Bull Market Continues To Unfold On Zomedica Corp (AMEX: ZOM), As It Continued To Rise 3.67% In Year-To-Date - Marketing Sentinel

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - ACCESS Newswire

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity - ACCESS Newswire

Noble Capital Markets Initiates Equity Research Coverage on Zomedica - ACCESS Newswire

Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened - Defense World

Geode Capital Management LLC Buys 321,395 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) - Defense World

Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s Why - Defense World

Zomedica (NYSEAMERICAN:ZOM) Shares Down 2.2%Should You Sell? - MarketBeat

Zomedica enters license and supply agreement with Cresilon Inc. - DVM 360

Zomedica Secures Exclusive U.S. Rights to Revolutionary Vetigel Bleeding Control Technology - StockTitan

Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health - AOL

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - AccessWire

Zomedica Expands TRUFORMA Platform with Breakthrough 20-Minute Cardiac and Breeding Diagnostic Tests - StockTitan

Zomedica appoints Scott Jordan as EVP, finance & CFO - MSN

Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s Why - Defense World

Zomedica Strengthens Leadership: Industry Veteran with 30+ Years Experience Named New CFO - StockTitan

Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8%Should You Sell? - MarketBeat

Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled - StockTitan

Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa

Zomedica secures new lease for headquarters expansion - Investing.com

Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat

Zomedica Corp (ZOM) 財務データ

収益

当期純利益

現金流量

EPS

ZOMに似た銘柄